Search Results - "BUMPUS, Namandjé N"

Refine Results
  1. 1

    Insights into protein post-translational modification landscapes of individual human cells by trapped ion mobility time-of-flight mass spectrometry by Orsburn, Benjamin C., Yuan, Yuting, Bumpus, Namandjé N.

    Published in Nature communications (25-11-2022)
    “…Single cell proteomics is a powerful tool with potential for markedly enhancing understanding of cellular processes. Here we report the development and…”
    Get full text
    Journal Article
  2. 2

    For better drugs, diversify clinical trials by Bumpus, Namandjé N

    “…Genetic variation in drug metabolism can affect drug outcomes COVID-19 has highlighted the devastating disparities that exist for Black, Latinx, and Indigenous…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Single-Stranded Nucleic Acids Bind to the Tetramer Interface of SAMHD1 and Prevent Formation of the Catalytic Homotetramer by Seamon, Kyle J, Bumpus, Namandjé N, Stivers, James T

    Published in Biochemistry (Easton) (08-11-2016)
    “…Sterile alpha motif and HD domain protein 1 (SAMHD1) is a unique enzyme that plays important roles in nucleic acid metabolism, viral restriction, and the…”
    Get full text
    Journal Article
  5. 5

    The role of FDA advisory committees by Helms Williams, Emily C., Bumpus, Namandjé N., Califf, Robert M.

    Published in Nature medicine (30-09-2024)
    “…FDA advisory committees provide useful recommendations for decision-making, but optimization efforts could help reduce burdens and improve public understanding…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice by Avery, Lindsay B, Bumpus, Namandjé N

    Published in Molecular pharmacology (01-01-2014)
    “…Valproic acid (VPA) is a widely prescribed anticonvulsant for the treatment of epilepsy. Here we demonstrate that VPA is a novel activator of AMP-activated…”
    Get more information
    Journal Article
  8. 8

    Naturally Occurring Mutations to Muscle-Type Creatine Kinase Impact Its Canonical and Pharmacological Activities in a Substrate-Dependent Manner In Vitro by Mosher, Eric P, Eberhard, Colten D, Bumpus, Namandjé N

    Published in Molecular pharmacology (01-12-2021)
    “…Tenofovir (TFV) is a key component of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). TFV is a nucleotide analog reverse-transcriptase…”
    Get full text
    Journal Article
  9. 9

    Pharmacogenomics of Antiretroviral Drug Metabolism and Transport by Yu, Zaikuan J, Mosher, Eric P, Bumpus, Namandjé N

    “…Antiretroviral therapy has markedly reduced morbidity and mortality for persons living with human immunodeficiency virus (HIV). Individual tailoring of…”
    Get full text
    Journal Article
  10. 10

    Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes by Bumpus, Namandjé N.

    Published in Toxicology and applied pharmacology (01-12-2011)
    “…Chronic use of efavirenz (EFV) has been linked to incidences of hepatotoxicity in patients receiving EFV to treat HIV-1. While recent studies have demonstrated…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism by Yanakakis, Lindsay J, Bumpus, Namandjé N

    Published in Drug metabolism and disposition (01-04-2012)
    “…Etravirine (ETR) is a second-generation non-nucleoside reverse transcriptase inhibitor prescribed for the treatment of HIV-1. By using human liver microsomes…”
    Get full text
    Journal Article
  13. 13

    Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc by Lu, Yanhui, Hendrix, Craig W, Bumpus, Namandjé N

    Published in Drug metabolism and disposition (01-12-2012)
    “…Maraviroc is an anti-human immunodeficiency virus drug that acts by blocking viral entry into target cells. With use of ultra-performance liquid…”
    Get full text
    Journal Article
  14. 14

    Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death by Heck, Carley J. S, Seneviratne, Herana Kamal, Bumpus, Namandjé N

    Published in Journal of medicinal chemistry (25-06-2020)
    “…Cytochrome P450-dependent metabolism of the anti-HIV drug nevirapine (NVP) to 12-hydroxy-NVP (12-OHNVP) has been implicated in NVP toxicities. We investigated…”
    Get full text
    Journal Article
  15. 15

    The SAGA HAT module is tethered by its SWIRM domain and modulates activity of the SAGA DUB module by Haile, Sara T., Rahman, Sanim, Fields, James K., Orsburn, Benjamin C., Bumpus, Namandjé N., Wolberger, Cynthia

    “…The SAGA (Spt-Ada-Gcn5 acetyltransferase) complex is a transcriptional co-activator that both acetylates and deubiquitinates histones. The histone…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Mechanism-Based Inactivation of Human Cytochromes P450s: Experimental Characterization, Reactive Intermediates, and Clinical Implications by Hollenberg, Paul F, Kent, Ute M, Bumpus, Namandjé N

    Published in Chemical research in toxicology (01-01-2008)
    “…The P450 type cytochromes are responsible for the metabolism of a wide variety of xenobiotics and endogenous compounds. Although P450-catalyzed reactions are…”
    Get full text
    Journal Article
  18. 18

    Efavirenz and Efavirenz-like Compounds Activate Human, Murine, and Macaque Hepatic IRE1 α -XBP1 by Heck, Carley J S, Hamlin, Allyson N, Bumpus, Namandjé N

    Published in Molecular pharmacology (01-02-2019)
    “…Efavirenz (EFV), a widely used antiretroviral drug, is associated with idiosyncratic hepatotoxicity and dyslipidemia. Here we demonstrate that EFV stimulates…”
    Get more information
    Journal Article
  19. 19

    Genetic variation of kinases and activation of nucleotide analog reverse transcriptase inhibitor tenofovir by Hamlin, Allyson N, Tillotson, Joseph, Bumpus, Namandjé N

    Published in Pharmacogenomics (01-01-2019)
    “…As antiretroviral therapy has become more accessible across the world and coformulations have improved patient compliance; the morbidity and mortality of…”
    Get full text
    Journal Article
  20. 20

    Human Biotransformation of the Nonnucleoside Reverse Transcriptase Inhibitor Rilpivirine and a Cross-Species Metabolism Comparison by LADE, Julie M, AVERY, Lindsay B, BUMPUS, Namandjé N

    Published in Antimicrobial Agents and Chemotherapy (01-10-2013)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article